Summary of RSU Grant to Named Executive Officers of Andrx Corporation (April 14, 2005)
Contract Categories:
Human Resources
›
Bonus & Incentive Agreements
Summary
This document summarizes the grant of Restricted Stock Units (RSUs) awarded on April 14, 2005, to key executives of Andrx Corporation and its subsidiary. The recipients include the CEO, President, EVP and General Counsel, and the President of Andrx Pharmaceuticals, Inc. Each executive received a specified number of RSUs as part of long-term performance and incentive awards. The summary outlines the total RSUs granted to each executive, reflecting their compensation and incentive arrangements for the period.
EX-10.98 2 g94614exv10w98.htm SUMMARY OF RSU AWARDS `Summary of RSU Awards
Exhibit 10.98
Summary of RSU Grant to Named Executive Officers
April 14, 2005
| Total RSUs | ||||||||||||
| Long-Term | Performance- | Awarded on | ||||||||||
| Named Executive Officer | Incentive Award | Based Award | April 14, 2005 | |||||||||
Thomas P. Rice Andrx Corporation CEO | 40,000 | 10,000 | 50,000 | |||||||||
Angelo C. Malahias Andrx Corporation President | 25,000 | 6,250 | 31,250 | |||||||||
Scott Lodin Andrx Corporation EVP and General Counsel | 20,000 | 5,000 | 25,000 | |||||||||
Lawrence Rosenthal, Andrx Pharmaceuticals, Inc. President | 20,000 | 5,000 | 25,000 | |||||||||
